Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPOXProstat: 18F-MISO PET in Prostate Cancer
NCT01898065Phase 2Completed
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Jun 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoromisonidazole in prostate adenocarcinoma, sponsored by Institut Cancérologique de l'Ouest. Started Jun 2012; status: completed.
02
Drugs
fluoromisonidazole
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT01898065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898065.